206 related articles for article (PubMed ID: 23942857)
1. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis.
Lauzier F; Arnold DM; Rabbat C; Heels-Ansdell D; Zarychanski R; Dodek P; Ashley BJ; Albert M; Khwaja K; Ostermann M; Skrobik Y; Fowler R; McIntyre L; Nates JL; Karachi T; Lopes RD; Zytaruk N; Finfer S; Crowther M; Cook D
Intensive Care Med; 2013 Dec; 39(12):2135-43. PubMed ID: 23942857
[TBL] [Abstract][Full Text] [Related]
2. Dalteparin versus unfractionated heparin in critically ill patients.
; Cook D; Meade M; Guyatt G; Walter S; Heels-Ansdell D; Warkentin TE; Zytaruk N; Crowther M; Geerts W; Cooper DJ; Vallance S; Qushmaq I; Rocha M; Berwanger O; Vlahakis NE
N Engl J Med; 2011 Apr; 364(14):1305-14. PubMed ID: 21417952
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.
Cook D; Douketis J; Meade M; Guyatt G; Zytaruk N; Granton J; Skrobik Y; Albert M; Fowler R; Hebert P; Pagliarello G; Friedrich J; Freitag A; Karachi T; Rabbat C; Heels-Ansdell D; Geerts W; Crowther M;
Crit Care; 2008; 12(2):R32. PubMed ID: 18315876
[TBL] [Abstract][Full Text] [Related]
4. Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients.
Li G; Cook DJ; Levine MAH; Guyatt G; Crowther M; Heels-Ansdell D; Holbrook A; Lamontagne F; Walter SD; Ferguson ND; Finfer S; Arabi YM; Bellomo R; Cooper DJ; Thabane L;
Medicine (Baltimore); 2015 Sep; 94(36):e1479. PubMed ID: 26356708
[TBL] [Abstract][Full Text] [Related]
5. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.
Rabbat CG; Cook DJ; Crowther MA; McDonald E; Clarke F; Meade MO; Lee KA; Cook RJ
J Crit Care; 2005 Dec; 20(4):357-63. PubMed ID: 16310608
[TBL] [Abstract][Full Text] [Related]
6. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
[TBL] [Abstract][Full Text] [Related]
7. Nonleg venous thrombosis in critically ill adults: a nested prospective cohort study.
Lamontagne F; McIntyre L; Dodek P; Heels-Ansdell D; Meade M; Pemberton J; Skrobik Y; Seppelt I; Vlahakis NE; Muscedere J; Reece G; Ostermann M; Padayachee S; Alhashemi J; Walsh M; Lewis B; Schiff D; Moody A; Zytaruk N; Leblanc M; Cook DJ; ; ;
JAMA Intern Med; 2014 May; 174(5):689-96. PubMed ID: 24638843
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
; ; ; Goligher EC; Bradbury CA; McVerry BJ; Lawler PR; Berger JS; Gong MN; Carrier M; Reynolds HR; Kumar A; Turgeon AF; Kornblith LZ; Kahn SR; Marshall JC; Kim KS; Houston BL; Derde LPG; Cushman M; Tritschler T; Angus DC; Godoy LC; McQuilten Z; Kirwan BA; Farkouh ME; Brooks MM; Lewis RJ; Berry LR; Lorenzi E; Gordon AC; Ahuja T; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Contreras A; Costantini TW; de Brouwer S; Detry MA; Duggal A; Džavík V; Effron MB; Eng HF; Escobedo J; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Froess JD; Fu Z; Galanaud JP; Galen BT; Gandotra S; Girard TD; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Haniffa R; Hegde SM; Hendrickson CM; Higgins AM; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Huang DT; Hudock K; Hunt BJ; Husain M; Hyzy RC; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski A; King AJ; Knudson MM; Kornblith AE; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Gallego Lima F; Linstrum K; Litton E; Lopez-Sendon J; Lother SA; Marten N; Saud Marinez A; Martinez M; Mateos Garcia E; Mavromichalis S; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nicolau JC; Nunez-Garcia B; Park JJ; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pompilio M; Quigley JG; Rosenson RS; Rost NS; Rowan K; Santos FO; Santos M; Santos MO; Satterwhite L; Saunders CT; Schreiber J; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Singhal AB; Slutsky AS; Solvason D; Stanworth SJ; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Widmer RJ; Wilson JG; Yuriditsky E; Zhong Y; Berry SM; McArthur CJ; Neal MD; Hochman JS; Webb SA; Zarychanski R
N Engl J Med; 2021 Aug; 385(9):777-789. PubMed ID: 34351722
[TBL] [Abstract][Full Text] [Related]
11. Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness.
Arnold DM; Lauzier F; Rabbat C; Zytaruk N; Barlow Cash B; Clarke F; Heels-Ansdell D; Guyatt G; Walter SD; Davies A; Cook DJ;
Thromb Res; 2013 Mar; 131(3):204-9. PubMed ID: 23317632
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia in medical surgical critical illness.
Warkentin TE; Sheppard JI; Heels-Ansdell D; Marshall JC; McIntyre L; Rocha MG; Mehta S; Davies AR; Bersten AD; Crozier TM; Ernest D; Vlahakis NE; Hall RI; Wood GG; Poirier G; Crowther MA; Cook DJ;
Chest; 2013 Sep; 144(3):848-858. PubMed ID: 23722881
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.
Crowther M; Cook D; Guyatt G; Zytaruk N; McDonald E; Williamson D; Albert M; Dodek P; Finfer S; Vallance S; Heels-Ansdell D; McIntyre L; Mehta S; Lamontagne F; Muscedere J; Jacka M; Lesur O; Kutsiogiannis J; Friedrich J; Klinger JR; Qushmaq I; Burry L; Khwaja K; Sheppard JA; Warkentin TE; ; ;
J Crit Care; 2014 Jun; 29(3):470.e7-15. PubMed ID: 24726205
[TBL] [Abstract][Full Text] [Related]
15. Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency.
Park D; Southern W; Calvo M; Kushnir M; Solorzano C; Sinnet M; Billett HH
J Gen Intern Med; 2016 Feb; 31(2):182-187. PubMed ID: 26209179
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
; ; ; Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR; Turgeon AF; Escobedo J; Huang DT; Bradbury CA; Houston BL; Kornblith LZ; Kumar A; Kahn SR; Cushman M; McQuilten Z; Slutsky AS; Kim KS; Gordon AC; Kirwan BA; Brooks MM; Higgins AM; Lewis RJ; Lorenzi E; Berry SM; Berry LR; Aday AW; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Costantini TW; de Brouwer S; Derde LPG; Detry MA; Duggal A; Džavík V; Effron MB; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Galanaud JP; Galen BT; Gandotra S; García-Madrona S; Girard TD; Godoy LC; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Hamburg NM; Haniffa R; Hanna G; Hanna N; Hegde SM; Hendrickson CM; Hite RD; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Hudock K; Hunt BJ; Husain M; Hyzy RC; Iyer VN; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski AL; King AJ; Knudson MM; Kornblith AE; Krishnan V; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Lima FG; Linstrum K; Litton E; Lopez-Sendon J; Lopez-Sendon Moreno JL; Lother SA; Malhotra S; Marcos M; Saud Marinez A; Marshall JC; Marten N; Matthay MA; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Moore SC; Morillo Guerrero R; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nunez-Garcia B; Pandey A; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pérez González YS; Pompilio M; Prekker ME; Quigley JG; Rost NS; Rowan K; Santos FO; Santos M; Olombrada Santos M; Satterwhite L; Saunders CT; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Shankar-Hari M; Sheehan JP; Singhal AB; Solvason D; Stanworth SJ; Tritschler T; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Wells BJ; Widmer RJ; Wilson JG; Yuriditsky E; Zampieri FG; Angus DC; McArthur CJ; Webb SA; Farkouh ME; Hochman JS; Zarychanski R
N Engl J Med; 2021 Aug; 385(9):790-802. PubMed ID: 34351721
[TBL] [Abstract][Full Text] [Related]
17. Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin.
Saheb Sharif-Askari F; Syed Sulaiman SA; Saheb Sharif-Askari N; Al Sayed Hussain A; Railey MJ
PLoS One; 2014; 9(9):e106517. PubMed ID: 25181525
[TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.
Pai M; Adhikari NKJ; Ostermann M; Heels-Ansdell D; Douketis JD; Skrobik Y; Qushmaq I; Meade M; Guyatt G; Geerts W; Walsh MW; Crowther MA; Friedrich JO; Burry L; Bellomo R; Brandão da Silva N; Costa Filho R; Cox MJ; Alves Silva S; Cook DJ;
PLoS One; 2018; 13(6):e0198285. PubMed ID: 29856817
[TBL] [Abstract][Full Text] [Related]
19. Dalteparin in critically ill patients.
Smythe MA; Koerber JM
N Engl J Med; 2011 Jul; 365(2):179-80; author reply 180. PubMed ID: 21751919
[No Abstract] [Full Text] [Related]
20. Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis.
Arabi YM; Al-Hameed F; Burns KEA; Mehta S; Alsolamy SJ; Alshahrani MS; Mandourah Y; Almekhlafi GA; Almaani M; Al Bshabshe A; Finfer S; Arshad Z; Khalid I; Mehta Y; Gaur A; Hawa H; Buscher H; Lababidi H; Al Aithan A; Abdukahil SAI; Jose J; Afesh LY; Al-Dawood A;
N Engl J Med; 2019 Apr; 380(14):1305-1315. PubMed ID: 30779530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
